Global X Management Co. LLC recently announced the acquisition of new stake in MyMD Pharmaceuticals Inc (NASDAQ:MYMD). The institutional investor has increased its shareholding in the Healthcare company by 4.31% to 0.93 million shares with purchase of 38615.0 shares. This fresh investment now brings its stake to 1.84% valued currently at $0.26 million. In addition, Geode Capital Management LLC raised its holdings by 8979.0 to 0.29 million shares. And Praetorian Wealth Management, Inc has lifted its position by 700.00% or 0.17 million shares – to 0.2 million shares.
With over 13.88 million MyMD Pharmaceuticals Inc (MYMD) shares trading Friday and a closing price of $0.26 on the day, the dollar volume was approximately $3.61 million. The shares have shown a negative half year performance of -82.75% and its price on 12/29/23 gained nearly 4.44%. Currently, there are 50.90M common shares owned by the public and among those 43.49M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The top 3 mutual fund holders in MyMD Pharmaceuticals Inc are Global X Cannabis ETF, Vanguard Total Stock Market ETF, and Vanguard Extended Market Index Fu. Global X Cannabis ETF owns 3.17 million shares of the company’s stock, all valued at over $0.89 million. Vanguard Extended Market Index Fu now owns shares totaling to 0.81% of the shares outstanding.
Shares of MyMD Pharmaceuticals Inc (NASDAQ: MYMD) opened at $0.24, down -$0.01 from a prior closing price of $0.25. However, the script later moved the day high at 0.3402, up 4.44%. The company’s stock has a 5-day price change of 13.46% and -56.30% over the past three months. MYMD shares are trading -77.50% year to date (YTD), with the 12-month market performance down to -76.48% lower. It has a 12-month low price of $0.20 and touched a high of $2.98 over the same period. MYMD has an average intraday trading volume of 973.74K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.51%, -18.22%, and -76.03% respectively.
Institutional ownership of MyMD Pharmaceuticals Inc (NASDAQ: MYMD) shares accounts for 8.51% of the company’s 50.90M shares outstanding. Mutual fund holders own 1.19%, while other institutional holders and individual stakeholders account for 10.16% and -1.65% respectively.
It has a market capitalization of $13.17M and a beta (3y monthly) value of 2.33. The earnings-per-share (ttm) stands at -$0.19. Price movements for the stock have been influenced by the stock’s volatility, which stands at 30.92% over the week and 16.59% over the month.
Analysts forecast that MyMD Pharmaceuticals Inc (MYMD) will achieve an EPS of $0 for the current quarter, $0 for the next quarter and $0 for 2019. The lowest estimate earnings-per-share for the quarter is $0 while analysts give the company a high EPS estimate of $0.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 1 brokerage firm advisors rate MyMD Pharmaceuticals Inc (MYMD) as a “Strong Buy” at a consensus score of 1.00. Specifically, 1 Wall Street analysts polled rate the stock as a buy, while 0 of the 1 advise that investors “hold,” and 0 rated it as a “Sell.”
